Literature DB >> 25452555

Use of human serum for human corneal endothelial cell culture.

Lucas Monferrari Monteiro Vianna1, Laura Kallay2, Tetsuya Toyono2, Rubens Belfort3, Jeffrey D Holiman4, Albert S Jun2.   

Abstract

BACKGROUND/AIMS: To study human corneal endothelial cells (HCECs) cultured in vitro with human serum (HS) supplemented media (HS-SM) compared with HCEC cultured in fetal bovine serum (FBS) supplemented media (FBS-SM).
METHODS: One cornea from a donor aged 21 years and a pair of corneas from a 16 year-old donor were obtained from the eye bank and used to create two different cell populations. At the first passage, the cell populations were equally divided and seeded in two different wells containing FBS-SM or HS-SM. In subsequent passages, HS-SM was compared with FBS-SM by morphology, growth curves, immunohistochemistry and real-time reverse-transcriptase PCR for endothelial cell markers.
RESULTS: No difference in morphology could be seen in P2, P5 or in any other passages for cells grown in the two media. By growth curves, cell counts were similar in FBS-SM and HS-SM from days 1 to 5, with a trend towards higher cell counts in HS-SM at day 7. Cells grown in FBS-SM and HS-SM media showed similar expression of endothelial cell markers when assessed by immunohistochemistry and real-time reverse-transcriptase PCR.
CONCLUSIONS: HS-SM was similar to FBS-SM for HCEC culture when assessed by cell morphology, proliferation and protein/gene expression. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cornea; Experimental &#8211 laboratory

Mesh:

Substances:

Year:  2014        PMID: 25452555     DOI: 10.1136/bjophthalmol-2014-306034

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Transcriptomic Analysis of Cultured Corneal Endothelial Cells as a Validation for Their Use in Cell Replacement Therapy.

Authors:  Ricardo F Frausto; Derek J Le; Anthony J Aldave
Journal:  Cell Transplant       Date:  2015-09-02       Impact factor: 4.064

Review 2.  Substrates for Expansion of Corneal Endothelial Cells towards Bioengineering of Human Corneal Endothelium.

Authors:  Jesintha Navaratnam; Tor P Utheim; Vinagolu K Rajasekhar; Aboulghassem Shahdadfar
Journal:  J Funct Biomater       Date:  2015-09-11

Review 3.  From DMEK to Corneal Endothelial Cell Therapy: Technical and Biological Aspects.

Authors:  Raffaele Nuzzi; Paola Marolo; Federico Tridico
Journal:  J Ophthalmol       Date:  2018-08-01       Impact factor: 1.909

4.  Arresting proliferation improves the cell identity of corneal endothelial cells in the New Zealand rabbit.

Authors:  Carlos-Alberto Rodríguez-Barrientos; Victor Trevino; Judith Zavala; María-Dolores Montalvo-Parra; Guillermo-Isaac Guerrero-Ramírez; Raul Aguirre-Gamboa; Jorge-Eugenio Valdez-García
Journal:  Mol Vis       Date:  2019-11-14       Impact factor: 2.367

Review 5.  Ex vivo expansion and characterization of human corneal endothelium for transplantation: a review.

Authors:  Ingrida Smeringaiova; Tor Paaske Utheim; Katerina Jirsova
Journal:  Stem Cell Res Ther       Date:  2021-10-30       Impact factor: 6.832

6.  High-throughput 3D microvessel-on-a-chip model to study defective angiogenesis in systemic sclerosis.

Authors:  Bart Kramer; Claudio Corallo; Angelique van den Heuvel; Justin Crawford; Thomas Olivier; Edo Elstak; Nicola Giordano; Paul Vulto; Henriette L Lanz; Richard A J Janssen; Michela A Tessari
Journal:  Sci Rep       Date:  2022-10-08       Impact factor: 4.996

7.  Regulatory Compliant Tissue-Engineered Human Corneal Endothelial Grafts Restore Corneal Function of Rabbits with Bullous Keratopathy.

Authors:  Gary S L Peh; Heng-Pei Ang; Chan N Lwin; Khadijah Adnan; Benjamin L George; Xin-Yi Seah; Shu-Jun Lin; Maninder Bhogal; Yu-Chi Liu; Donald T Tan; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.